ArticleDrug delivery and translational research2025

Construction and evaluation of liposomal drug delivery system for an ALK/HDACs dual-targeted inhibitor with sustained release and enhanced antitumor effect.

Fang Ren et al.PubMed ↗Publisher ↗

No numbers read from the abstract.